Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04281186Completed

Retinal and Cognitive Dysfunction in Type 2 Diabetes

Role: collaborator

NCT05565170Not ApplicableActive Not Recruiting

Digitally Supported Lifestyle Programme to Promote Brain Health Among Older Adults

Role: collaborator

NCT05159661Recruiting

Intelligent Digital Tools for Screening of Brain Connectivity and Dementia Risk Estimation in People Affected by Mild Cognitive Impairment

Role: collaborator

NCT02017340Phase 3Completed

A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease

Role: collaborator

All 4 trials loaded